22 May 2013
Keywords: elan, in-licenses, gw, ultiva, pharma, ltd, signed
Article | 27 January 2000
Elan Pharma Ltd has signed a deal to in-license Glaxo Wellcome'sintravenous analgesic Ultiva (remifentanil HCl) for the UK market.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 November 1999
© 2013 thepharmaletter.com